More timely antimicrobial susceptibility testing as a tool in combatting antimicrobial resistance in clinically relevant microorganisms: Is there more than one way to skin a cat?

Clinical Microbiology Newsletter

Volumn 36, Issue 19, 2014, Pages 149-153

  Dunne, William Michael ^a   van Belkum, Alex ^b  

^a BIOMÉRIEUX   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOANALYSIS; BACTERIAL GROWTH; BACTERIAL INFECTION; BROTH DILUTION; CALORIMETRY; CLOSTRIDIUM DIFFICILE; DIAGNOSTIC ACCURACY; DISK DIFFUSION; ESCHERICHIA COLI; FLOW CYTOMETER; FLOW CYTOMETRY; GENE SEQUENCE; HUMAN; INCUBATION TIME; ISOTHERMAL MICROCALORIMETRY; KLEBSIELLA PNEUMONIAE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL BIOMASS; NEXT GENERATION SEQUENCING; NONHUMAN; PRESCRIPTION; SALMONELLA; SPINNING MAGNETIC BEAD; SYSTEM ANALYSIS; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; VIBRATING CANTILEVER; VIBRIO CHOLERAE;

EID: 84908381287     PISSN: 01964399     EISSN: 18734391     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2014.09.001     Document Type: Article

References (46)

1. van Belkum A., Dunne W.M. Next-generation antimicrobial susceptibility testing. J. Clin. Microbiol. 2013, 51:2018-2024.
2. Dunne W.M., Westblade L.F., Ford B. Next generation and whole genome sequencing in the diagnostic clinical microbiology laboratory. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 8:1719-1726.
3. Hoof G.P., et al. Characterization of b-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry. J. Proteome Res. 2012, 11:79-84.
4. Syrmis M.W., et al. Comparison of a multiplexed MassARRAY system with real-time allele-specific PCR technology for genotyping of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 2011, 17:1804-1810.
5. Maranach C., et al. MALDI_TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole. Proteomics. 2009, 9:4627-4631.
6. Machen A., Drake T., Wang Y.F. Same day identification and full panel antimicrobial susceptibility testing of bacteria from positive blood culture bottles made possible by a combined lysis-filtration method with MALDI-TOF VITEK mass spectrometry and the VITEK2 System. PLoS One 2014, 9:e87870.
7. Rudensky B., et al. Rapid flow-cytometry susceptibility testing of Candida species. J. Antimicrob. Chemother. 2005, 5:106-109.
8. Fredericks B.A., et al. Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry. J. Microbiol. Methods 2006, 67:266-272.
9. Faria-Ramos I., et al. A novel flow cytometric assay for rapid detection of extended-spectrum beta-lactamases. Clin. Microbiol. Infect. 2013, 19:E8-E15.
10. Douglas I.S., et al. 2011. Rapid microbiological identification and major drug resistance phenotyping with novel multiplexed automated digital microscopy (MADM) for ventilator-associated pneumonia (VAP) surveillance, poster A3928. ATS 2011 International Conference, Denver, CO, 13-15 May 2011.
11. Knudsen S.M., et al. Determination of bacterial antibiotic resistance based on osmotic shock response. Anal. Chem. 2009, 81:7087-7090.
12. Gfeller K.Y., Nugaeva N., Hegner M. Rapid biosensor for detection of antibiotic-selective growth of Escherichia coli. Appl. Environ. Microbiol. 2005, 71:2626-2631.
13. von Ah U., Wirz D., Daniels A.U. Isothermal micro calorimetry-a new method for MIC determinations: results for 12 antibiotics and reference strains of Escherichia coli and Staphylococcus aureus. BMC Microbiol. 2009, 9:106.
14. Furustrand Tafin U., Meis J.F., Trampuz A.J. Isothermal microcalorimetry for antifungal susceptibility testing of Mucorales, Fusarium spp., and Scedosporium spp. Diagn. Microbiol. Infect. Dis. 2012, 73:330-337.
15. Howell M., et al. Application of a microcalorimetric method for determining drug susceptibility in Mycobacterium species. J. Clin. Microbiol. 2012, 50:16-20.
16. Kinnunen P., et al. Self-assembled magnetic bead biosensor for measuring bacterial growth and antimicrobial susceptibility testing. Small 2012, 8:2477-2482.
17. Boitard L., et al. Monitoring single-cell bioenergetics via the coarsening of emulsion droplets. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:7181-7186.
18. Banaiee N., et al. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico. J. Clin. Microbiol. 2001, 39:3883-3888.
19. Burnham C.A., et al. Rapid ertapenem susceptibility testing and Klebsiella pneumoniae carbapenemase phenotype detection in Klebsiella pneumoniae isolates by use of automated microscopy of immobilized live bacterial cells. J. Clin. Microbiol. 2014, 52:982-986.
20. Athamneh A.I., et al. Phenotypic profiling of antibiotic response signatures in Escherichia coli using Raman spectroscopy. Antimicrob. Agents Chemother. 2014, 58:1302-1314.
21. Hasman H., et al. Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples. J. Clin. Microbiol. 2014, 52:139-146.
22. Reuter S., et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern. Med. 2013, 173:1397-1404.
23. Schijffelen M., et al. Whole genome analysis of epidemiologically closely related Staphylococcus aureus isolates. PLoS One 2013, 8:e78340.
24. Arena F., et al. Rapid resistome fingerprinting and clonal lineage profiling of carbapenem-resistant Klebsiella pneumoniae isolates by targeted next-generation sequencing. J. Clin. Microbiol. 2014, 52:987-990.
25. Snitkin E.S., et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci. Transl. Med. 2012, 4:148ra116.
26. Harris S.R., et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect. Dis. 2013, 13:130-136.
27. Köser C.U., et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N. Engl. J. Med. 2012, 366:2267-2275.
28. Wright M.S., et al. New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis. MBio 2014, 5:e00963-13.
29. Eyre D.W., et al. Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission. J. Clin. Microbiol. 2013, 51:4141-4149.
30. Grad Y.H., et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect. Dis. 2014, 14:220-226.
31. Turabelidze G., et al. Precise dissection of an Escherichia coli O157:H7 outbreak by single nucleotide polymorphism analysis. J. Clin. Microbiol. 2013, 51:3950-3954.
32. Mather A.E., et al. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science 2013, 341:1514-1517.
33. Grad Y.H., Waldor M.K. Deciphering the origins and tracking the evolution of cholera epidemics with whole-genome-based molecular epidemiology. MBio 2013, 4:e00670-13.
34. Rishishwar L., et al. Genome sequence-based discriminator for vancomycin-intermediate Staphylococcus aureus. J. Bacteriol. 2014, 196:940-948.
35. Matsuo M., et al. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3. Antimicrob. Agents Chemother. 2013, 57:5843-5853.
36. Sass P., et al. Genome sequence of Staphylococcus aureus VC40, a vancomycin- and daptomycin-resistant strain, to study the genetics of development of resistance to currently applied last-resort antibiotics. J. Bacteriol. 2012, 194:2107-2108.
37. Peleg A.Y., et al. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus. PLoS One 2012, 7:e28316.
38. Su H.C., et al. Comparative genome analysis of ciprofloxacin-resistant Pseudomonas aeruginosa reveals genes within newly identified high variability regions associated with drug resistance development. Microb. Drug Resist. 2013, 19:428-436.
39. Zhang H., et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat. Genet. 2013, 45:1255-1260.
40. Farhat M.R., et al. Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat. Genet. 2013, 45:1183-1189.
41. Köser C.U., et al. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N. Engl. J. Med. 2013, 369:290-292.
42. Dutilh B.E., et al. Explaining microbial phenotypes on a genomic scale: GWAS for microbes. Brief Funct. Genomics 2013, 12:366-380.
43. Zankari E., et al. Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. J. Antimicrob. Chemother. 2013, 68:771-777.
44. Kumar V., et al. Comparative genomics of Klebsiella pneumoniae strains with different antibiotic resistance profiles. Antimicrob. Agents Chemother. 2011, 55:4267-4276.
45. Stoesser N., et al. Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J. Antimicrob. Chemother. 2013, 68:2234-2244.
46. Gordon N.C., et al. Prediction of Staphylococcus aureus antimicrobial resistance from whole genome sequencing. J. Clin. Microbiol. 2014, 52:1182-1191.